PPX™ – Autologous Exosomes (2 vials of 1mL each)

PPX™ – Autologous Exosomes is the first-of-its-kind, autologous-homologous exosome therapy that harnesses the patient’s own regenerative biology to deliver high-concentration extracellular vesicles (EVs) and exosomes. Created through a proprietary, non-expanded plasma processing technique, PPX™ isolates and concentrates hundreds of billions of naturally occurring nanoparticles from the patient’s blood, resulting in a potent, acellular biologic ideal for tissue regeneration, skin rejuvenation, and hair restoration.

Unlike synthetic or donor-derived exosome products, PPX™ is 100% autologous, ensuring maximum compatibility, no risk of immune response, and superior regenerative signaling. This advanced formulation supports cellular communication, boosts healing and repair, and enhances homeostatic balance in treated tissues.

Key Benefits:

• Autologous-derived for personalized regenerative therapy

• Contains billions of exosomes and EVs per milliliter

• Promotes collagen synthesis, angiogenesis, and tissue remodeling

• Stimulates hair regrowth and restores skin vitality

• Delivers over 300+ growth factors, cytokines, and signaling molecules

• Contains microRNAs, enzymes, and proteins to support cellular reprogramming

• No additives, preservatives, or culture expansion – 100% natural

• Ideal for use with microneedling, PRP, RF, and laser therapy

Biological Composition:

• Extracellular Vesicles (EVs)

• Exosomes (a subclass of EVs)

• Hyaluronic Acid (HA)

• 300+ Growth Factors, Cytokines & Chemokines

• Signaling Components: mRNA, microRNA, enzymes, lipids, and cell surface proteins

Processing & Delivery:

• Derived from plasma precipitate fraction using a proprietary process

• Acellular, non-HCT/P biologic

• Does not require cell culture or expansion

• Fully autologous—minimizing rejection or adverse reactions

• Includes a 3-step logistics process:

  1. Shipment of PPX collection kit to the physician

  2. Overnight return of blood specimen to the lab

  3. Overnight frozen delivery of final product (on dry ice) to clinic

• Must be stored at -20°C to maintain nanoparticle viability